Newtopia

About Newtopia

Newtopia Inc. is a technology-enabled healthcare company specializing in habit change to prevent, slow, and reverse chronic diseases. Founded in 2008 by Jeff Ruby and Jean-Jacques Dugoua, the company was born from Ruby's personal experience after his father passed away from cancer that was largely attributed to lifestyle choices. This motivated Ruby to shift the healthcare focus from treating sickness to proactive prevention. Before Newtopia, Ruby co-founded several other health-focused ventures, including Cleveland Clinic Canada, Life Screening Centers Inc., and Genetic Diagnostics Inc., demonstrating a consistent entrepreneurial journey in preventative health. He holds a joint JD/MBA from York University's Osgoode Hall Law School and Schulich School of Business.

The company primarily serves large U.S. employers, health plans, and supplemental insurance payviders as a B2B platform. Its business model is subscription-based, involving a one-time fee for a welcome kit and a recurring monthly fee per engaged participant. Newtopia also incorporates outcome-based milestones, such as a fee triggered by a 5% reduction in a participant's body weight. The company went public on the TSX Venture Exchange (TSXV: NEWU) and is also quoted on the OTCQB Venture Market (OTCQB: NEWUF).

Newtopia's platform creates hyper-personalized prevention programs by leveraging genetic testing, social insights, and behavioral science. It focuses on conditions like metabolic syndrome, type 2 diabetes, heart disease, hypertension, and weight management. Participants receive a highly individualized experience that combines virtual care from personality-matched coaches (called 'Inspirators'), digital tools for tracking progress, and connected devices like wearable biosensors. The platform's unique selling point is its '1:1' approach, using genetic and behavioral data to design personalized diet and exercise plans that move beyond generic, one-size-fits-all programs. Recently, Newtopia has expanded its services to include support programs for individuals using GLP-1 medications, aiming to help them sustain weight loss and health benefits long-term.